Back to Search
Start Over
298 - T cell activation and anti-tumor efficacy of anti-Lag3 mAbs are independent of Lag-3–MHC Class II blocking capacity.
- Source :
-
European Journal of Cancer . Dec2016 Supplement 1, Vol. 69, pS98-S98. 1p. - Publication Year :
- 2016
Details
- Language :
- English
- ISSN :
- 09598049
- Volume :
- 69
- Database :
- Academic Search Index
- Journal :
- European Journal of Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 120140890
- Full Text :
- https://doi.org/10.1016/S0959-8049(16)32891-X